T1	Participants 133 157	advanced ovarian cancer.
T2	Participants 164 267	May 1978 until November 1980, 169 previously untreated patients with advanced epithelial ovarian cancer
T3	Participants 462 477	Eleven patients
T4	Participants 570 651	153 patients evaluable for response, there were 47, or 30.7%, complete responders
T5	Participants 1102 1114	158 patients
